Juvenescence Ltd.
Juvenescence Ltd.
Biotech company focused on developing therapies to extend human healthspan and lifespan.
About
Technology stack
detected 2026-06-24“Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42.”
View on Reddit“Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42.”
View on Reddit“G3 and Juvenescence partner on deep learning venture - Longevity.Technology.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
What does Juvenescence Ltd. do?
Juvenescence Ltd. is a biotechnology company dedicated to the research and development of novel therapies aimed at combating aging and age-related diseases. The company's focus is on identifying and advancing interventions that can extend human healthspan and lifespan, thereby improving the quality of life for older adults.
How much funding has Juvenescence Ltd. raised?
Juvenescence Ltd. has raised a total of $150M in funding. The most recent round on record is Series B.
Where is Juvenescence Ltd. headquartered?
Juvenescence Ltd. is headquartered in George Town, Cayman Islands.
When was Juvenescence Ltd. founded?
Juvenescence Ltd. was founded in 2017.
What industry does Juvenescence Ltd. operate in?
Juvenescence Ltd. operates in Biotech, HealthTech, Longevity, Drug Discovery, Clinical Trials, Epigenetic Reprogramming.
What is Juvenescence Ltd.'s revenue?
StartupHub estimates Juvenescence Ltd.'s annual revenue at $15.5M (range $4.5M to $66.9M, 31% confidence), based on comparable companies in the sector.
What is Juvenescence Ltd.'s valuation?
StartupHub estimates Juvenescence Ltd.'s effective valuation at $579.2M (range $375.0M to $900.0M, 10% confidence), based on comparable companies in the sector.